Poole Robert Michael's most recent trade in Ovid Therapeutics Inc was a trade of 30,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 22, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Ovid Therapeutics Inc | Poole Robert Michael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
Ovid Therapeutics Inc | Robert Michael Poole | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
Ovid Therapeutics Inc | Robert Michael Poole | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2021 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) |